Progenerative Medical entered into a technology licensing agreement with Kinetic Concepts (an Acelity company), obtaining exclusive, worldwide rights to intellectual property and a preclinical product development portfolio enabling effective delivery of negative pressure therapy for orthopaedic and spine indications.
The license enables development of a negative pressure technology specifically tailored for musculoskeletal applications.
In its 2Q16 revenue call, Smith & Nephew leadership noted the addition of a warranty/combination program to its Syncera sales model, offering implants plus PICO and ACTICOAT wound products. When used post-op, SNN essentially guarantees against a surgical site infection over the 90-day episode of care.
Progenerative Medical entered into a technology licensing agreement with Kinetic Concepts (an Acelity company), obtaining exclusive, worldwide rights to intellectual property and a preclinical product development portfolio enabling effective delivery of negative pressure therapy for orthopaedic and spine indications.
The license enables...
Progenerative Medical entered into a technology licensing agreement with Kinetic Concepts (an Acelity company), obtaining exclusive, worldwide rights to intellectual property and a preclinical product development portfolio enabling effective delivery of negative pressure therapy for orthopaedic and spine indications.
The license enables development of a negative pressure technology specifically tailored for musculoskeletal applications.
In its 2Q16 revenue call, Smith & Nephew leadership noted the addition of a warranty/combination program to its Syncera sales model, offering implants plus PICO and ACTICOAT wound products. When used post-op, SNN essentially guarantees against a surgical site infection over the 90-day episode of care.
Copy to clipboard 
